Product Program year 2025 Source: CMS Open Payments

GORE VIABAHN Endoprosthesis

Device Devices

PDI 00733132623310

Open in the dashboard

General payments

$773,828

2,823 payments

Research payments

$0

0 payments

Through program year 2025, $773,828 in general payments and $0 in research payments were reported against GORE VIABAHN Endoprosthesis (Devices).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $272,239 786
2024 General $153,532 495
2023 General $152,415 607
2022 General $102,275 520
2021 General $93,368 415

Breakdown

Who paid General payments · program years 2021–2025
  1. W. L. Gore & Associates, Inc. $773,828 2,823 payments
Top recipients General payments · program year 2025
  1. David Zielske Vascular & Interventional Radiology · Nashville, TN $45,974 17% · 4 payments
  2. Daniel Patel Nephrology · Daytona Beach, FL $20,736 8% · 15 payments
  3. Nathan Liang Vascular Surgery · Pittsburgh, PA $20,324 7% · 6 payments
  4. Darren Schneider Vascular Surgery · Philadelphia, PA $19,706 7% · 3 payments
  5. William Gray Interventional Cardiology · Wynnewood, PA $18,760 7% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Vascular Surgery Surgery $153,699 56% · 191 practitioners
  2. Vascular & Interventional Radiology Radiology $56,917 21% · 41 practitioners
  3. Interventional Cardiology Internal Medicine $32,469 12% · 15 practitioners
  4. Nephrology Internal Medicine $22,290 8% · 36 practitioners
  5. Surgery $1,957 <1% · 26 practitioners

The top 5 of 24 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Pennsylvania $67,303 25% · 16 recipients
  2. Tennessee $48,941 18% · 11 recipients
  3. Florida $29,223 11% · 27 recipients
  4. North Carolina $18,543 7% · 23 recipients
  5. Virginia $15,832 6% · 7 recipients

The top 5 of 39 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

2,823 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record